Targeting ABC transporters in pancreatic ductal carcinoma—past, present, or future?
A new editorial paper titled "Targeting ABC transporters in PDAC—past, present, or future?" has been published in Oncotarget.
Jul 10, 2024
0
0
A new editorial paper titled "Targeting ABC transporters in PDAC—past, present, or future?" has been published in Oncotarget.
Jul 10, 2024
0
0
Using genetic engineering techniques, investigators at the Johns Hopkins Kimmel Cancer Center and its Ludwig Center, the Lustgarten Laboratory and Bloomberg~Kimmel Institute for Cancer Immunotherapy have designed a novel ...
Jul 10, 2024
0
45
A study led by the Hospital del Mar Research Institute, with Cima University of Navarra and Pompeu Fabra University, has identified a group of small molecules exclusive to liver tumors that could be key to developing cancer ...
Jul 10, 2024
0
37
In August 2023, a team of researchers including Dr. Eduard Porta, group leader at the Josep Carreras Institute, published a thorough analysis of the effects of cancer driver alterations found across different cancer types, ...
Jul 10, 2024
0
0
In chronic hepatitis B, the liver contains immune cells that could destroy hepatitis B virus infected cells but are inactive. A team from the Technical University of Munich (TUM) has discovered that cells in blood vessels ...
Jul 10, 2024
0
38
Researchers from Queen Mary University London and Emory University used a novel AI-based analytic tool to better understand how tumor infiltrating lymphocytes (TILs) can predict which cases of Ductal Carcinoma in Situ (DCIS) ...
Jul 10, 2024
0
8
CAR-T cell therapy, which targets a specific protein on the surface of cancer cells, causes tumors to shrink or disappear in about half of patients with large B-cell lymphoma who haven't experienced improvement with chemotherapy ...
Jul 10, 2024
0
9
A research team from the School of Chinese Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed) has made a remarkable discovery that patients with non-alcoholic fatty liver disease (commonly known as fatty ...
Jul 10, 2024
0
36
Certain types of light have proven to be an effective, minimally-invasive treatment for cancers located on or near the skin when combined with a light-activated drug. But deep-seated cancers, surrounded by tissue, blood and ...
Jul 9, 2024
0
108
A new research paper was published in Oncotarget titled, "Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers and overcomes cancer stemness, trifluridine-induced angiogenesis, ERK1/2 and STAT3 signaling ...
Jul 9, 2024
0
0